Ecuabaldra S.A.

General Information

IndustryHealth and pharmaceutical

Organisation typeCompany

Company Address Alborada XII Etapa C.C. Gran Albocentro Of E-7,
090501, Guayaquil,
Guayas, Ecuador

Phone number00593987165565

Web page

Company Address

Contact Information

Contact Person Ms. Karina Kuonqui
Special Attorney



Verified By

OrganisationEco. Lassi Pensikkala

Project typeDistribution of hospital and medical technology, and instruments from Finland;
Joint venture

Project abstractEcuabaldra S.A., the Ecuadorian company specialised in import, sale and distribution of medical technology and instruments, is searching for Finnish manufacturers and distributors of medical equipment’s to import and distribute their products in Ecuador

Project descriptionEcuabaldra S.A. established in 2013 is based in Guayaquil, Ecuador and currently employs 5 persons.

The company operates in import, sale and distribution of medical and hospital supplies, technical support to hospital staff in the management of medical supplies, and sale of medical equipment. Ecuabaldra S.A. has a strong experience in the Ecuadorian market. It means for Finnish business partners following: Advantage in knowledge of the business environment within public and private hospitals in Ecuador, the company has a good credit credibility, trained personnel to manage medical business areas, established and operating since 2013, and good relationship with health control institution in Ecuador.

The customers so far have been hospital market throughout the Ecuador.

The company is currently looking for a partner in Finland to increase the number of products for the hospital market in the following lines: Neonatal cardiac surgery, Complementary lines to their current business, and General hospital services, technology and supplies.


Number of employees5

Annual turnover in €0.5-2 million

Annual balance sheet total0.5-2 million

Certifications, standardsReg Mercantil Constitución Cía Ecuabaldra

Already engaged in international co-operationYes

Percentage of transnational activities10 to 49%